SAVA Stock Price | Cassava Sciences Inc. Stock Quote (U.S.: Nasdaq)
SAVA | Complete Cassava Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Source: marketwatch.com
Page 36 - Cassava Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cassava Sciences Today - Breaking & Trending Today
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer's Disease
Simufilam Slowed Cognitive Decline by 38% Versus Placebo Over 6 months in Patients with Mild-to-Moderate Alzheimer’s Disease.Drug Effects Favored Mild Alzheimer’s Disease.In Mild...
Source: marketscreener.com
Promising Alzheimer's Treatment: Cassava Sciences' Simufilam Slows Cognitive Decline by 38% in Clinical Study - Cassava Sciences (NASDAQ:SAVA)
Cassava Sciences Inc (NASDAQ: SAVA) announced topline clinical results from its Cognition Maintenance Study (CMS), a small proof-of-concept study designed to demonstrate the effects of simufilam versus placebo in a
Source: benzinga.com
Why Cassava Sciences Stock Is Trading Down Today - Cassava Sciences (NASDAQ:SAVA)
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading lower Wednesday.
Source: benzinga.com
Cassava Sciences Stock Slips 14%
Shares of Cassava Sciences, Inc. (SAVA) are slipping over 14% on Wednesday morning. SAVA is currently trading at $21.66, down $3.66 or 14.45%, on the Nasdaq. The stock opened its trading at $26.
Source: rttnews.com